Last $5.13 USD
Change Today +0.14 / 2.81%
Volume 10.4K
BONE On Other Exchanges
Symbol
Exchange
NYSE Amex
As of 10:39 AM 09/18/14 All times are local (Market data is delayed by at least 15 minutes).

bacterin international holdi (BONE) Key Developments

Bacterin International Holdings, Inc. Appoints David Goodman as New Board Member

Bacterin International Holdings, Inc. announced the addition of David Goodman, MD, MSE to the board of directors. Dr. Goodman brings extensive experience in executive management through previous roles as CEO of SEDLine and EVP of Business Development for Masimo. The Board unanimously elected Dr. Goodman to fill the vacancy created by Mitchell Godfrey's recent resignation. Dr. Goodman currently serves as Co-Founder and CMO of FirstVitals Health & Wellness, a technology-enabled service company focused on preventing complications such as foot ulcers and lower extremity amputations in people with diabetes. He also serves on the board of NEUROMetrix and was previously on the board of Sound Surgical prior to its acquisition by Solta Medical.

Bacterin International Holdings, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

Bacterin International Holdings, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company's total revenue was $8,883,932 against $8,266,848 a year ago. Loss from operations was $1,332,009 against $1,866,984 a year ago. Net loss was $1,900,430 or $0.35 basic and dilutive per share against $2,483,091 or $0.55 basic and dilutive per share a year ago. EBITDA was $769,645 against $1,427,054 a year ago. For the six months, the company's total revenue was $17,796,902 against $16,885,655 a year ago. Loss from operations was $2,524,010 against $3,100,403 a year ago. Net loss was $6,040,685 or $1.11 basic and dilutive per share against $4,152,349 or $0.94 basic and dilutive per share a year ago. EBITDA was $1,484,829 against $2,491,767 a year ago.

Bacterin International Mulls Acquisitions; Files For Offering

Bacterin International Holdings, Inc. (AMEX:BONE) has filed a follow-on equity offering and make seek acquisitions. The company intends to use the net proceeds from this offering primarily for working capital and general corporate purposes. General corporate purposes may include providing working capital, funding capital expenditures, or paying for acquisitions.

Bacterin International Holdings, Inc. to Report Q2, 2014 Results on Aug 12, 2014

Bacterin International Holdings, Inc. announced that they will report Q2, 2014 results After-Market on Aug 12, 2014

Bacterin International Holdings, Inc. Files Certificate of Amendment of Restated Certificate of Incorporation

Bacterin International Holdings, Inc. filed a Certificate of Amendment of Restated Certificate of Incorporation with the Delaware Secretary of State. The Amendment provides that each ten shares of the company's common stock will be reclassified and combined into one share of common stock effective July 25, 2014. The Reverse Stock Split will be effective for trading purposes beginning July 28, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BONE:US $5.13 USD +0.14

BONE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Biolase Inc $2.70 USD +0.005
Cytori Therapeutics Inc $1.01 USD -0.01
Stereotaxis Inc $2.48 USD +0.0116
Uroplasty Inc $2.47 USD 0.00
Vision Sciences Inc/DE $1.04 USD +0.02
View Industry Companies
 

Industry Analysis

BONE

Industry Average

Valuation BONE Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.8x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BACTERIN INTERNATIONAL HOLDI, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.